Home
Conditions
Hepadnaviridae Infections

Clinical trial condition

Hepadnaviridae Infections

Explore clinical trials studying Hepadnaviridae Infections. Study availability and eligibility vary by location and protocol.

1,149 public trials 113 recruiting studies

Refine in advanced search Browse all conditions

Hepadnaviridae Infections trial results

Completed

An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B

NCT00467545

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Novartis Investigative Site (705-035) Daegu, South Korea

Novartis Investigative Site , (420-717) Gyeonggi-do, South Korea

Novartis Investigative Site , (405-760) Incheon, South Korea

Novartis Investigative Site , (136-705) Seoul, South Korea

View Trial Details

Completed

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

NCT00646503

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Novartis Investigative Site Beijing, China

View Trial Details

Completed

Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly

NCT01457495

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib, Compared to DTPa-HBV-IPV and Hib Administered Separately

NCT01457508

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +36 more
Locations: Not specified

View Trial Details

Completed

Telbivudine Versus the Combination of Telbivudine and Valtorcitabine in Patients With Chronic Hepatitis B

NCT00128544

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Pokfulam, Hong Kong

Auckland, New Zealand

Singapore

View Trial Details

Completed

Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects

NCT01480622

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: GSK Investigational Site Shanghai, China

View Trial Details

Completed

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

NCT01747772

Conditions: Blood-Borne Infections, Chemical and Drug Induced Liver Injury, Chemically-Induced Disorders, +26 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

NCT02443233

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Department of Obstetrics and Gynaecology Hong Kong, China

View Trial Details

Completed

The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers

NCT03180333

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Nanjing First Hospital Nanjing, Jiangsu, China

View Trial Details

Completed

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

NCT01453348

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +27 more
Locations: 03, Novartis Investigational Site Berlin, Germany

02, Novartis Investigational Site Hamburg, Germany

01, Novartis Investigational Site München, Germany

04, Novartis Investigational Site Rostock, Germany

View Trial Details

Hepadnaviridae Infections

Hepadnaviridae Infections trial results

Related conditions